Sign in
Stories
Advancements in Cell Therapies and Sickle Cell Disease Treatment
Share
Advancements in Cell Therapies and Sickl...
CASGEVY™ Gene-Edited Therapy Approval in...
Advancements in Sickle Cell Disease Trea...
Affini-T Therapeutics at J.P. Morgan Hea...
BMS Showcases Diverse Approaches in Mult...
Overview
API
Orca Bio presents promising data at ASH Annual Meeting for its investigational cell therapies, Orca-T and Orca-Q, demonstrating potential for expanding treatment to additional patient groups. FDA approvals for gene therapies for sickle cell disease at ASH. CAR-T cell therapy shows promise in treating autoimmune diseases like lupus. Study highlights challenges in caring for people with sickle cell disease.
Ask a question
How can the challenges in caring for people with sickle cell disease be addressed through advancements in healthcare and technology?
How might the potential expansion of Orca-T and Orca-Q's treatment to additional patient groups impact the landscape of cell therapies for cancer?
What are the implications of the FDA's approval of gene therapies for sickle cell disease on patient care and treatment options?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Coverage